Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Rochem, your partner in developing, sourcing, and supplying pharmaceutical & animal health ingredients of Chinese origin.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Together we can improve the quality of life

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Trastuzumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,808,443Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 11Herceptin

    02 4Kanjinti

    03 4Ontruzant

    04 7Phesgo

    05 3Trazimera

    PharmaCompass
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    Brand Name : Herceptin

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Herceptin

    Switzerland
    arrow
    IPPE
    Not Confirmed

    Roche

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2019 Revenue in Millions : 6,220

    2018 Revenue in Millions : 7,191

    Growth (%) : -14

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    Brand Name : Kanjinti

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Kanjinti

    U.S.A
    arrow
    IPPE
    Not Confirmed

    Amgen

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 567

    2019 Revenue in Millions : 226

    Growth (%) : 151

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    Brand Name : Herceptin

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Herceptin

    Switzerland
    arrow
    IPPE
    Not Confirmed

    Roche

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2020 Revenue in Millions : 4,158

    2019 Revenue in Millions : 6,729

    Growth (%) : -38

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    Brand Name : Kanjinti

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Kanjinti

    U.S.A
    arrow
    IPPE
    Not Confirmed

    Amgen

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 572

    2020 Revenue in Millions : 567

    Growth (%) : 1

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    Brand Name : Phesgo

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Phesgo

    Switzerland
    arrow
    IPPE
    Not Confirmed

    Roche

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 366

    2020 Revenue in Millions : 24

    Growth (%) : 1,378

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    Brand Name : Phesgo

    Pertuzumab, Trastuzumab, Hyaluronidase

    arrow
    IPPE
    Not Confirmed

    Brand Name : Phesgo

    Switzerland
    arrow
    IPPE
    Not Confirmed

    Roche

    Pertuzumab, Trastuzumab, Hyaluronidase

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 366

    2020 Revenue in Millions : 24

    Growth (%) : 1,378

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    Brand Name : Trazimera

    Trastuzumab-qyyp

    arrow
    IPPE
    Not Confirmed

    Brand Name : Trazimera

    U.S.A
    arrow
    IPPE
    Not Confirmed

    Pfizer Inc.

    Trastuzumab-qyyp

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 197

    2020 Revenue in Millions : 98

    Growth (%) : 101

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    Brand Name : Ontruzant

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Ontruzant

    U.S.A
    arrow
    IPPE
    Not Confirmed

    Organon

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 126

    2020 Revenue in Millions : 115

    Growth (%) : 10

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    Brand Name : Herceptin

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Herceptin

    Switzerland
    arrow
    IPPE
    Not Confirmed

    Roche

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2021 Revenue in Millions : 2,899

    2020 Revenue in Millions : 3,956

    Growth (%) : -28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    Brand Name : Ontruzant

    Trastuzumab

    arrow
    IPPE
    Not Confirmed

    Brand Name : Ontruzant

    U.S.A
    arrow
    IPPE
    Not Confirmed

    Organon

    Trastuzumab

    Main Therapeutic Indication : Oncology

    Currency : USD

    2022 Revenue in Millions : 122

    2021 Revenue in Millions : 126

    Growth (%) : -3

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.